M Ventures

company

About

M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.

  • 11 - 50

Details

Industries
Biotechnology,Life Science,Pharmaceutical,Semiconductor,Venture Capital
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
CVC,Venture Capital

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Investments

Number of Investments
Number of Lead Investments
8
2
M Ventures has made 8 investments. Their most recent investment was on Dec 14, 2022, when Storm Therapeutics raised $30M.
Date Company Name
Round Money Raised Industry Lead Investor
Series B $30M Biotechnology Yes
Feb 25, 2021 Medisafe
Series C $30M Health Care
Jul 14, 2020 iOnctura
Series A €5.10M Biotechnology
Jan 23, 2020 iOnctura
Series A €15M Biotechnology
Series A £14M Biotechnology